Table 1 Demographic and tumour characteristics of prostate cancer patients at baseline by ADT exposure

From: Cardiovascular disease risk and androgen deprivation therapy in patients with localised prostate cancer: a prospective cohort study

 

ADT not used ( N =5467)

ADT used ( N =2170)

Total ( N =7637)

P-value

Age, years

65

2072 (37.9)

430 (19.8)

2502 (32.8)

<0.0001

>65

3395 (62.1)

1740 (80.2)

5135 (67.2)

 

Charlson score 1 year before PC diagnoses

0

2716 (60.3)

826 (52.7)

3542 (58.4)

<0.0001

1–2

1426 (31.7)

584 (37.3)

2010 (33.1)

 

3+

361 (8.0)

157 (10.0)

518 (8.5)

 

Missing

964

603

1567

 

Race/ethnicity

Hispanic

793 (14.5)

312 (14.4)

1105 (14.5)

0.0097

White

3356 (61.4)

1292 (59.5)

4648 (60.9)

 

African-American

856 (15.7)

405 (18.7)

1261 (16.5)

 

Asian

462 (8.5)

161 (7.4)

623 (8.2)

 

Hypertension

No

2237 (40.9)

789 (36.4)

3026 (39.6)

0.0002

Yes

3230 (59.1)

1381 (63.6)

4611 (60.4)

 

Diabetes

No

4572 (83.6)

1729 (79.7)

6301 (82.5)

<0.0001

Yes

895 (16.4)

441 (20.3)

1336 (17.5)

 

Year of PC diagnosis

1998–2000

1256 (23.0)

826 (38.1)

2082 (27.3)

<0.0001

2001–2005

2465 (45.1)

899 (41.4)

3364 (44.0)

 

2006+

1746 (31.9)

445 (20.5)

2191 (28.7)

 

Stage at diagnosis

T1

3726 (69.1)

1196 (55.8)

4922 (65.3)

<0.0001

T2

1600 (29.7)

837 (39.0)

2437 (32.3)

 

T3

69 (1.3)

112 (5.2)

181 (2.4)

 

Missing

72

25

97

 

Gleason score

<7

3388 (69.0)

851 (42.3)

4239 (61.2)

<0.0001

7

1088 (22.1)

631 (31.4)

1719 (24.8)

 

>7

437 (8.9)

528 (26.3)

965 (13.9)

 

Missing

554

160

714

 

Risk groups

Low

2218 (47.7)

389 (19.2)

2607 (39.1)

<0.0001

Intermediate

1398 (30.1)

637 (31.5)

2035 (30.5)

 

High

1030 (22.2)

997 (49.3)

2027 (30.4)

 

Missing

821

147

968

 

Preexisting CVD

No

4290 (78.5)

1682 (77.5)

5972 (78.2)

0.3598

Yes

1177 (21.5)

488 (22.5)

1665 (21.8)

 

Smoking status a

Current

451 (12.8)

190 (12.9)

641 (12.8)

0.0078

Former

1472 (41.7)

680 (46.1)

2152 (43.0)

 

Never

1611 (45.6)

605 (41.0)

2216 (44.2)

 

Missing

1933

695

2628

 

BMI b

Underweight or normal

498 (30.0)

172 (38.0)

670 (31.7)

0.0098

Overweight

729 (43.9)

181 (40.0)

910 (43.0)

 

Obese

435 (26.2)

100 (22.1)

535 (25.3)

 
  1. Abbreviations: ADT=androgen deprivation therapy; BMI=body mass index; CVD=cardiovascular disease; PC=prostate cancer.
  2. P-value based on Pearson’s chi-square test, two-sided.
  3. a35% was missing, smoking history was not available in EMR until 2004.
  4. b72% missing, BMI was not available in EMR until 2006.